Differences in disease prevalence as a source of the US European health care spending gap

被引:46
作者
Thorpe, Kenneth E. [1 ]
Howard, David H. [1 ]
Galactionova, Katya [1 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA
关键词
D O I
10.1377/hlthaff.26.6.w678
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The United States spends more on health care than any European country. Previous studies have sought to explain these differences in terms of system capacity, access to technologies, gross domestic product, and prices. We examine differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries using surveys of the noninstitutionalized population age fifty and older. Disease prevalence and rates of medication treatment are much higher in the United States than in these European countries. Efforts to reduce the U.S. prevalence of chronic illness should remain a key policy goal.
引用
收藏
页码:W678 / W686
页数:9
相关论文
共 31 条
[1]  
ANDERSON, ITS RPICES STUPID
[2]   It's the prices, stupid: Why the United States is so different from other countries [J].
Anderson, GF ;
Reinhardt, UE ;
Hussey, PS ;
Petrosyan, V .
HEALTH AFFAIRS, 2003, 22 (03) :89-105
[3]  
ANGRISANO, ACCOUNTING COST HLTH
[4]  
[Anonymous], 2007, ACCOUNTING COST HLTH
[5]  
[Anonymous], DIAB PROGR FACTS FIG
[6]  
BANKS, IARC CANC INCIDENCE
[7]  
BANKS, DIS DISADVANTAGE
[8]   Disease and disadvantage in the United States and in England [J].
Banks, J ;
Marmot, M ;
Oldfield, Z ;
Smith, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17) :2037-2045
[9]  
BIGELOW JH, 2005, ANAL HEALTHC INTERVE
[10]  
Cutler D. M., 2006, W12124 NBER